Isabel Rauscher
Papers
1
Total Citations
30
H-Index
1
About
Isabel Rauscher is a leading figure in the field of nuclear medicine and molecular imaging, with a focused expertise in theranostics for prostate cancer. Her most impactful work centers on the development and clinical application of PSMA-ligand technology, particularly for guiding surgical interventions. Her seminal 2018 paper, "Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands," has garnered 30 citations and established a foundational approach for intraoperative detection of metastatic lesions. This contribution has directly improved the precision of salvage lymphadenectomy, enabling surgeons to remove cancerous tissue that is invisible to conventional imaging. Rauscher’s research bridges the gap between diagnostic imaging and targeted therapy, demonstrating how radiolabeled PSMA ligands can serve as both a diagnostic tool and a surgical roadmap. Her work is highly regarded for its translational impact, offering a tangible improvement in the management of biochemical recurrence. With a growing citation footprint, Rauscher continues to shape the future of personalized, image-guided cancer care.
Research Focus
Key Achievements
Top Papers
- 1